Tumor stroma

被引:0
|
作者
Seljelid, R [1 ]
Jozefowski, S [1 ]
Sveinbjörnsson, B [1 ]
机构
[1] Univ Tromso, Fac Med, Dept Expt Pathol, N-9037 Tromso, Norway
关键词
cancer; stroma; macrophages; mast cells; immunomodulation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The accumulated evidence indicates that tumor stroma with its cells and cell products plays a much more active and important role than previously believed. Growth factors and cytokines produced by macrophages and other cells are crucial for stroma formation and angiogenesis. Lytic enzymes provided by stromal cells may be essential for invasion. TNF and other inflammatory mediators may be operative in the systemic effects of tumors, e.g. cachexia. All these effects may come about through the action of soluble substances produced by tumor cells ol by more intimate interactions. There is no evidence that stromal cells are directly involved in carcinogenesis- i.e. the cellular transformation to produce the malignant cell. On the other hand, stromal cells and other components of the interstitia me instrumental in tumorigenesis - i.e. the development of a real malignant tumor from its start on the cellular or subcellular level. In one way of looking at it, the stromal cells, e.g. macrophages may be considered as "slaves", kept to carry out certain functions, synthesize essential substances e.g. growth factors that the tumor cells do not have the capacity ol the degree of finely tuned machinery to produce. The objective of immunomodulation should then be to create a "slave uprising", to make the macrophages and other cells turn against their masters, stop producing growth factors and start producing harmful factors that would lend to the elimination of the malignant growth. The first target of immunomodulation in tumor disease should probably be local malignancies where no effective treatment exists today- and selected cases of metastatic prevention (181,182).
引用
收藏
页码:4809 / 4822
页数:14
相关论文
共 50 条
  • [1] The fibrotic tumor stroma
    Yamauchi, Mitsuo
    Barker, Thomas H.
    Gibbons, Don L.
    Kurie, Jonathan M.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (01): : 16 - 25
  • [2] Tumor-stroma crosstalk: targeting stroma in breast cancer
    Criscitiello, Carmen
    Esposito, Angela
    Curigliano, Giuseppe
    [J]. CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 551 - 555
  • [3] Tumor stroma in DCIS progression
    West, Robert
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [4] Genomic Alterations in Tumor Stroma
    Eng, Charis
    Leone, Gustavo
    Orloff, Mohammed S.
    Ostrowski, Michael C.
    [J]. CANCER RESEARCH, 2009, 69 (17) : 6759 - 6764
  • [5] Tumor microenvironment: The role of the tumor stroma in cancer
    Li, Hanchen
    Fan, Xueli
    Houghton, JeanMarie
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (04) : 805 - 815
  • [6] Ovarian tumor with functioning stroma
    Tanaka, YO
    Ide, Y
    Nishida, M
    Nishide, K
    Tsunoda, H
    Kajitani, M
    Itai, Y
    [J]. COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2002, 26 (03) : 193 - 197
  • [7] Tumor-stroma interactions
    Bhowmick, NA
    Moses, HL
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) : 97 - 101
  • [8] The Role of Stroma in Tumor Development
    Werb, Zena
    Lu, Pengfei
    [J]. CANCER JOURNAL, 2015, 21 (04): : 250 - 253
  • [9] Stroma - Tumor agonist or antagonist
    Proia, DA
    Kuperwasser, C
    [J]. CELL CYCLE, 2005, 4 (08) : 1022 - 1025
  • [10] Shed proteoglycans in tumor stroma
    Zoi Piperigkou
    Benedikt Mohr
    Nikos Karamanos
    Martin Götte
    [J]. Cell and Tissue Research, 2016, 365 : 643 - 655